Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study

Abstract

Background

Lupus nephritis (LN) affects up to 80% of juvenile-onset systemic lupus erythematosus (JSLE) patients. The value of commonly available biomarkers, such as anti-dsDNA antibodies, complement (C3/C4), ESR and full blood count parameters in the identification of active LN remains uncertain.

Methods

Participants from the UK JSLE Cohort Study, aged <16 years at diagnosis, were categorized as having active or inactive LN according to the renal domain of the British Isles Lupus Assessment Group score. Classic biomarkers: anti-dsDNA, C3, C4, ESR, CRP, haemoglobin, total white cells, neutrophils, lymphocytes, platelets and immunoglobulins were assessed for their ability to identify active LN using binary logistic regression modeling, with stepAIC function applied to select a final model. Receiver-operating curve analysis was used to assess diagnostic accuracy.

Results

A total of 370 patients were recruited; 191 (52%) had active LN and 179 (48%) had inactive LN. Binary logistic regression modeling demonstrated a combination of ESR, C3, white cell count, neutrophils, lymphocytes and IgG to be best for the identification of active LN (area under the curve 0.724).

Conclusions

At best, combining common classic blood biomarkers of lupus activity using multivariate analysis provides a ‘fair’ ability to identify active LN. Urine biomarkers were not included in these analyses. These results add to the concern that classic blood biomarkers are limited in monitoring discrete JSLE manifestations such as LN.

Keywords

Lupus nephritis classic biomarkers ESR anti-dsDNA complement C3 C4

Get full access to this article

View all access options for this article.

References

Mina

Brunner

. Pediatric lupus – are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? Rheum Dis Clin North Am 2010; 36: 53–80.

Watson

Leone

Pilkington

et al.

Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort. Arthritis Rheum 2012; 64: 2356–2365.

Touma

Urowitz

Ibanez

Gladman

. Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment. J Rheumatol 2014; 41: 688–697.

Zhang

Sun

Jin

. Spot urine protein/creatinine ratio is unreliable estimate of 24 h proteinuria in lupus nephritis when the histological scores of activity index are higher. Lupus 2015; 24: 943–947.

Ishizaki

Saito

Nawata

et al.

Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2015; 54: 405–412.

Martinez-Martinez

Borjas-Garcia

Magana-Aquino

Cuevas-Orta

Llamazares-Azuara

Abud-Mendoza

. Renal function assessment in patients with systemic lupus erythematosus. Rheumatol Int 2012; 32: 2293–2299.

Isenberg

Rahman

Allen

et al.

BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group’s disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford) 2005; 44: 902–906.

R Core Team. R: A language and environment for statistical computing R Foundation for Statistical Computing. Vienna, Austria 2013, http://www.r-project.org (accessed 18 March 2017).

Barr

Magder

Petri

. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2350–2357.

10.

Swaak

Groenwold

Bronsveld

. Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis 1986; 45: 359–366.

11.

Moroni

Radice

Giammarresi

et al.

Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann Rheum Dis 2009; 68: 234–237.

12.

Edelbauer

Kshirsagar

Riedl

et al.

Markers of childhood lupus nephritis indicating disease activity. Pediatr Nephrol 2011; 26: 401–410.

13.

Stojan

Fang

Magder

Petri

. Erythrocyte sedimentation rate is a predictor of renal and overall SLE disease activity. Lupus 2013; 22: 827–834.

14.

Esdaile

Joseph

Abrahamowicz

Danoff

Clarke

. Routine immunologic tests in systemic lupus erythematosus: is there a need for more studies? J Rheumatol 1996; 23: 1891–1896.

15.

Moroni

Quaglini

Radice

et al.

The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy. J Immunol Res 2015; 2015: 106904–106904.

16.

Spronk

Bootsma

Kallenberg

. Anti-DNA antibodies as early predictor for disease exacerbations in SLE. Guideline for treatment? Clin Rev Allergy Immunol 1998; 16: 211–218.

17.

Smith

Jorgensen

Midgley

et al.

International validation of a urinary biomarker panel for identification of active lupus nephritis in children. Pediatr Nephrol 2017; 32: 283–295.

18.

Yee

Farewell

Isenberg

et al.

The BILAG-2004 index is sensitive to change for assessment of SLE disease activity. Rheumatology (Oxford) 2009; 48: 691–695.

19.

Zickert

Palmblad

Sundelin

et al.

Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis. Arthritis Res Ther 2012; 14: R36–R36.

20.

Watson

Midgley

Ballantine

et al.

Monocyte chemoattractant protein 1 is expressed from kidney epithelial cells in response to activated macrophages in juvenile-onset systemic lupus erythematosis (JSLE). Ann Rheum Dis 2012; 41: 72–72.

21.

Rubinstein

Pitashny

Levine

et al.

Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology (Oxford) 2010; 49: 960–971.

22.

Marks

Shah

Pilkington

Tullus

. Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis. Pediatr Nephrol 2010; 25: 2283–2288.

23.

Hinze

Suzuki

Klein-Gitelman

et al.

Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum 2009; 60: 2772–2781.